PCV14 AN APPRAISAL OF REAL-WORLD EVIDENCE (RWE) IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (NVAF) TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS (NOACS)

Value in Health ◽

10.1016/j.jval.2019.04.450 ◽

2019 ◽

Vol 22 ◽

pp. S120

Author(s):

S. Deitelzweig ◽

A. Cichewicz ◽

M. DiFusco ◽

A. Kang ◽

C. Russ ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Real World Evidence

Download Full-text

Comparative Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants (NOACS) And Warfarin In The Scottish Atrial Fibrillation Population: The Value of Real World Evidence

Value in Health ◽

10.1016/j.jval.2017.08.1163 ◽

2017 ◽

Vol 20 (9) ◽

pp. A603

Author(s):

G Ciminata ◽

C Geue ◽

O Wu ◽

M Deidda ◽

N Kreif ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Comparative Effectiveness ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Real World Evidence

Download Full-text

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation

Journal of Market Access & Health Policy ◽

10.1080/20016689.2019.1574541 ◽

2019 ◽

Vol 7 (1) ◽

pp. 1574541 ◽

Author(s):

Craig I. Coleman ◽

Jean-Baptiste Briere ◽

Laurent Fauchier ◽

Pierre Levy ◽

Kevin Bowrin ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Meta Analysis ◽

Vitamin K Antagonists ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Real World Evidence

Download Full-text

Impact of methodological choices on a meta-analysis of real-world evidence comparing non-vitamin-K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation

Current Medical Research and Opinion ◽

10.1080/03007995.2019.1647020 ◽

2019 ◽

Vol 35 (11) ◽

pp. 1867-1872 ◽

Author(s):

Jean-Baptiste Briere ◽

Olivia Wu ◽

Kevin Bowrin ◽

Aurélie Millier ◽

Mondher Toumi ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Meta Analysis ◽

Vitamin K Antagonists ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Methodological Choices ◽

Real World Evidence

Download Full-text

Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillation

Journal of Medical Economics ◽

10.1080/13696998.2019.1606001 ◽

2019 ◽

Vol 22 (8) ◽

pp. 760-765 ◽

Author(s):

Jean-Baptiste Briere ◽

Kevin Bowrin ◽

Aurélie Millier ◽

Mondher Toumi ◽

Piotr Wojciechowski ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Stroke Prevention ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Number Needed To Treat ◽

Real World Evidence

Download Full-text

Non-vitamin K Antagonist Oral Anticoagulants and Cognitive Impairment in Atrial Fibrillation: Insights From the Meta-Analysis of Over 90,000 Patients of Randomized Controlled Trials and Real-World Studies

Frontiers in Aging Neuroscience ◽

10.3389/fnagi.2018.00258 ◽

2018 ◽

Vol 10 ◽

Author(s):

Chi Zhang ◽

Zhi-Chun Gu ◽

Long Shen ◽

Mang-Mang Pan ◽

Yi-Dan Yan ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cognitive Impairment ◽

Randomized Controlled Trials ◽

Vitamin K ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Randomized Controlled

Download Full-text

Real-world comparisons of reduced-dose non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation: a systematic review and meta-analysis

Heart Failure Reviews ◽

10.1007/s10741-019-09887-x ◽

2019 ◽

Vol 25 (6) ◽

pp. 973-983 ◽

Author(s):

Xiaoping Wang ◽

Lili Fang ◽

Bin Liu ◽

Yongliang Zheng ◽

Junquan Zeng

Keyword(s):

Atrial Fibrillation ◽

Systematic Review ◽

Vitamin K ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Download Full-text

Decreased risk of renal impairment in atrial fibrillation patients receiving non-vitamin K antagonist oral anticoagulants: A pooled analysis of randomized controlled trials and real-world studies

Thrombosis Research ◽

10.1016/j.thromres.2018.12.010 ◽

2019 ◽

Vol 174 ◽

pp. 16-23 ◽

Author(s):

Chi Zhang ◽

Zhi-Chun Gu ◽

Zheng Ding ◽

Long Shen ◽

Mang-Mang Pan ◽

...

Keyword(s):

Atrial Fibrillation ◽

Renal Impairment ◽

Randomized Controlled Trials ◽

Vitamin K ◽

Oral Anticoagulants ◽

Pooled Analysis ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Randomized Controlled

Download Full-text

4366Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol

European Heart Journal ◽

10.1093/eurheartj/ehy563.4366 ◽

2018 ◽

Vol 39 (suppl_1) ◽

Author(s):

M A Esteve Pastor ◽

J M Rivera-Caravaca ◽

V Roldan ◽

E Orenes-Pinero ◽

G F Romiti ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist

Download Full-text

Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data

Heart Failure Reviews ◽

10.1007/s10741-019-09878-y ◽

2019 ◽

Vol 25 (6) ◽

pp. 957-964 ◽

Author(s):

Zhengbiao Xue ◽

Yue Zhou ◽

Chaoyu Wu ◽

Jie Lin ◽

Xin Liu ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Real World Data ◽

The Real ◽

Download Full-text

Comparison of non-vitamin K antagonist oral anticoagulants and well-controlled warfarin in octogenarians with non-valvular atrial fibrillation: Real-world data from a single tertiary center

The Anatolian Journal of Cardiology ◽

10.5152/anatoljcardiol.2021.25058 ◽

2021 ◽

Author(s):

Arzu Neslihan Akgun ◽

◽

Emir Karacaglar ◽

Ugur Abbas Bal ◽

Mehmet Bulent Ozin ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Real World Data ◽

Tertiary Center

Download Full-text